Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety

This article outlines a roadmap to influence incentives, regulations, new drug development, and ultimately stakeholder (i.e., patients, providers, and drug makers) behavior to enhance competition, with the ultimate aim of improving the quality and safety of healthcare for our patients.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research